Project Grant S10OD040222
- Federal Project Grant Award Summary The National Institutes of Health (NIH) Office of the Director awarded $1.00 through the Research Infrastructure Programs (CFDA 93.351) to the University of Texas Health Science Center at San Antonio on July 15, 2025, with a completion date of July 14, 2026. The grant funds the acquisition and installation of a 10X Genomics Xenium Analyzer, a high-resolution spatial transcriptomics and proteomics instrument to be housed in the Genome Sequencing Facility...
- Federal Grant Award Summary The University of Texas Health Science Center at San Antonio received a $346,350 Project Grant from the National Institutes of Health (NIH) Office of the Director under the Research Infrastructure Programs (CFDA 93.351) to install a helium capture and reliquification system for its Nuclear Magnetic Resonance (NMR) facility. The award, obligated on August 1, 2025, with a completion date of July 31, 2026, funds site preparation and installation of equipment designed...
- Federal Grant Award Summary The Ohio State University Comprehensive Cancer Center received a $433,700 Project Grant award from the National Institutes of Health Office of the Director under the Research Infrastructure Programs (CFDA 93.351) to acquire an Oxford Nanopore Technologies PromethION 24 long-read sequencing instrument. The award, dated May 1, 2026 with completion expected by April 30, 2027, supports the purchase and implementation of this third-generation sequencing platform at the...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded a Project Grant of $433,125 to The University of Texas Health Science Center at San Antonio, effective June 1, 2026, through January 31, 2031, under the Biomedical Research and Research Training program (CFDA 93.859). This award funds research on the spatiotemporal regulation of DNA metabolism pathways, specifically investigating how homologous recombination (HR) proteins are dynamically...
- Federal Project Grant Summary Award Overview: Emory University received $1.08 million in Research Infrastructure Programs (CFDA 93.351) funding from the National Institutes of Health Office of the Director, awarded on May 15, 2025, for acquisition of an Illumina NovaSeq X Plus high-throughput DNA sequencer. The grant supports the Emory National Primate Research Center Genomics Core's replacement of its existing NovaSeq 6000 system with the enhanced NovaSeq X Plus platform, which will serve...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded The University of Texas Health Science Center at San Antonio a $378,000 Project Grant effective May 1, 2026, through April 30, 2031, under the Biomedical Research and Research Training program (CFDA 93.859). This five-year project funds fundamental research investigating how intrinsically disordered proteins and intrinsically disordered regions regulate critical nuclear processes including...
- Federal Grant Award Summary The University of Texas Health Science Center at San Antonio received a $385,639 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through June 30, 2030. The award funds basic biomedical research investigating the molecular architecture and function of synaptic AMPA (A-amino-3-hydroxy-5-methyl-4-isoxazolepropionic) receptor complexes. The...
- Federal Project Grant Award Summary The University of Southern California's Keck Genomics Platform (KGP) received a $341,529 Project Grant from the National Institutes of Health (NIH) Office of the Director under the Research Infrastructure Programs (CFDA 93.351) on August 15, 2025, with completion targeted for August 14, 2026. The award supports the acquisition, installation, and integration of the Hamilton NGS STAR automated liquid handling system to enhance next-generation sequencing (NGS)...
- Federal Project Grant Award Summary The University of Texas at Austin received a $385,065 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 15, 2025, through August 31, 2030. This award supports fundamental research utilizing cryo-electron microscopy (cryo-EM) to elucidate the structure and function of macromolecular machines involved in gene regulation. The primary research...
- Federal Grant Award Summary The National Cancer Institute awarded a $404,972 Project Grant to The University of Texas Health Science Center at San Antonio under the Cancer Biology Research program (CFDA 93.396) for a two-year project period beginning August 1, 2025 and concluding July 31, 2027. This award supports fundamental research investigating ribosomal ribonucleic acid (rRNA) modification, ribosome composition, and specialized translation mechanisms in glioblastoma, the most common and...
The University of Texas Health Science Center at San Antonio (UTHSCSA) received a $750,000 Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Research Infrastructure Programs (CFDA 93.351) to acquire an Illumina NovaSeq X sequencing system for the Genome Sequencing Facility (GSF) at the Greehey Children's Cancer Research Institute. The award, issued on May 15, 2026, with a completion date of May 14, 2027, will support the installation and integration of this high-capacity sequencing platform into UTHSCSA's campus-wide shared core facility. The NovaSeq X system will augment the facility's existing sequencing infrastructure—currently consisting of one Illumina NovaSeq 6000 and one NextSeq 2000—and serve as the primary next-generation sequencing (NGS) platform accessible to researchers across the San Antonio region. The instrumentation will enable the GSF to provide cost-effective, high-quality sequencing data to support NIH-funded biomedical research conducted by 15 major users and 21 additional users across diverse research areas including cancer, aging, pain management, immunology, diabetes, infectious disease, and neurodegenerative diseases. The facility's experienced bioinformatics staff will provide integrated genomic analysis services to support basic, translational, and clinical research initiatives. The acquisition will enhance training opportunities for pre- and post-doctoral researchers and strengthen UTHSCSA's institutional commitment to advancing genomic research capabilities across the institution and the broader regional research community.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $750.0k | 5/7/26 |